MARATTO

article · Journal of Enzyme Inhibition and Medicinal Chemistry

A multidisciplinary approach to the antioxidant and hepatoprotective activities of <i>Arbutus pavarii</i> Pampan fruit; <i>in vitro</i> and <i>in Vivo</i> biological evaluations, and <i>in silico</i> investigations

202319 citationsOpen accessBadr University in Cairo

Abstract

Pampan (ARB), is an endemic Jebel Akhdar plant used for traditional medicine. This study presents the antioxidant and hepatoprotective properties of ARB fruit-extract. ARB phytochemical analysis indicated the presence of 354.54 GAE and 36.2 RE of the phenolics and flavonoids. LC-MS analysis identified 35 compounds belonging to phenolic acids, procyanidins, and flavonoid glycosides. Gallic acid, procyanidin dimer B3, β-type procyanidin trimer C, and quercetin-3-O-glucoside were the major constituents of the plant extract. ARB administration to paracetamol (PAR)-intoxicated rats reduced serum ALT, AST, bilirubin, hepatic tissue MDA and proinflammatory markers; TNF-α and IL-6 with an increase in tissue GSH level and SOD activity. Histological and immunohistochemical studies revealed that ARB restored the liver histology and significantly reduced the tissue expression of caspase 3, IL-1B, and NF-KB in PAR-induced liver damage. Docking analysis disclosed good binding affinities of some compounds with XO, COX-1, 5-LOX, and PI3K.

Research topics

  • Natural Antidiabetic Agents Studies
  • Phytochemicals and Antioxidant Activities
  • Plant biochemistry and biosynthesis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/14756366.2023.2293639

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.